Abstract
The pharmacist, as the medicines expert, should be able to assess the quality and safety of a biopharmaceutical and needs to know which criteria to use for the evaluation. A checklist incorporates the regulatory requirements and gives guidance when choosing biopharmaceuticals and biosimilars.
Original language | English |
---|---|
Pages (from-to) | 73-76 |
Number of pages | 4 |
Journal | EJHP Practice |
Volume | 14 |
Issue number | 1 |
Publication status | Published - 2008 |
Research programs
- EMC OR-01-34-01